State Street’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

State Street’s Portfolio BIOSU Stock Details BIOSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,451	Closed	-$186K	–	4647
2023 Q2	$186K	Hold	18,451	–	–	﹤0.01%	4027
2023 Q1	$193K	Hold	18,451	–	–	﹤0.01%	4088
2022 Q4	$189K	Hold	18,451	–	–	﹤0.01%	4122
2022 Q3	$185K	Hold	18,451	–	–	﹤0.01%	4181
2022 Q2	$186K	Hold	18,451	–	–	﹤0.01%	4231
2022 Q1	$184K	Buy	+18,451	New	+$184K	﹤0.01%	4410

Other funds holding BIOSU

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street's BIOSU Position: Q3 2023 in Review

State Street sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q3 2023, closing a stake of 18,451 shares — an estimated $186K sold.

State Street first reported a position in BIOSU in Q1 2022 and held it in 6 quarters. The position peaked at $193K in Q1 2023. 2 funds tracked by Wall St. Rank hold BIOSU as of Q3 2023.

State Street reported no remaining BioPlus Acquisition Corp. Unit position as of Q3 2023 after selling out during the quarter.
State Street sold 18,451 BioPlus Acquisition Corp. Unit shares in Q3 2023, an estimated $186K.
State Street first reported a position in BioPlus Acquisition Corp. Unit in Q1 2022 and held it in 6 quarters.
State Street's BioPlus Acquisition Corp. Unit position peaked at $193K in Q1 2023.
2 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.